Canature Health released its 2026 interim report. First-half net profit attributable to the parent was RMB 40.41 million, down 39.61% year on year. Operating revenue was RMB 921 million, up 1.47% year on year. Net profit attributable to the parent after deducting non-recurring items was RMB 25.21 million, down 60.25% year on year. Net operating cash flow was RMB 157 million, up 5.38% year on year. Earnings per share were RMB 0.0661. In the second quarter, operating revenue was RMB 504 million, up 4.1% year on year, and net profit attributable to the parent was RMB 35.06 million, down 22.7% year on year. As of the end of the second quarter, total assets were RMB 3.53 billion, down 4.0% from the end of the previous year, and net assets attributable to the parent were RMB 1.267 billion, up 0.5% from the end of the previous year. The company's main business has not undergone any major changes, and it continues to focus on the research, development, manufacturing, sales and service of residential water treatment products.
Shanghai Canature EnvironmentalNet profit attributable to parent fell 39.61% year on year to RMB 40.41 million.
